Where the future works: the Novartis Campus
Bottneuro Featured by Switzerland Innovation Park Basel Area: Empowering Patients and Driving Innovation from the Novartis Campus
Sachs Associates 12th Annual Healthtech Investment Forum
Bottneuro CSO, Alois Hopf, PhD, and Bottneuro AG Board Member Antonella Santuccione Chadha, MD, had a talk at the Sachs Associates 12th Annual Healthtech Investment Forum October 7, 2025 in Basel, Switzerland.
Dr Antonella Santuccione Chadha joins the Board of Directors at Bottneuro
It is an honor to welcome Dr. Antonella Santuccione Chadha to the Board of Directors at Bottneuro AG - bringing her extensive expertise to build our clinical strategy, supporting the company’s mission to bring precision neuromodulation solutions to Alzheimer’s disease and beyond.
